Pre-admission virus detection during the COVID-19 pandemic in children with and without symptoms of infection
© 2024 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica..
AIM: Pre-admission viral screening is used only in exceptional situations such as pandemics. We therefore evaluated pre-admission screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respiratory syncytial virus (RSV) and influenza during the COVID-19 pandemic, comparing epidemiology and clinical features of admitted children.
METHODS: Children were screened at a paediatric emergency department from 1 March 2020 to 30 June 2022 by nasopharyngeal sampling and polymerase chain reaction kit. We retrospectively retrieved positive results from the laboratory and scrutinised charts of admitted children.
RESULTS: Out of 15 927 screened children, 522, 127 and 572 were positive and admitted with RSV, influenza A or SARS-CoV-2, respectively. Of these, 29 (5.6%), 26 (24.1%) and 245 (44.8%) were incidental findings, lacking symptoms of infection. RSV and influenza A were initially absent but re-emerged in the autumn of 2021. The rate of COVID-19 rose when the Omicron variant emerged in December 2021. The median age of children with RSV was 0.3 years, of those with influenza A 6.7 years and of those with COVID-19 1.6 years. Major complications were rare.
CONCLUSION: Frequent incidental detections of SARS-CoV-2 likely reflected widespread presence of a mild infection. Clinically, COVID-19 was like other viral respiratory infections in children.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Acta paediatrica (Oslo, Norway : 1992) - (2024) vom: 06. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bennet, Rutger [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 06.03.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1111/apa.17195 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369355474 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM369355474 | ||
003 | DE-627 | ||
005 | 20240306233748.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240306s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/apa.17195 |2 doi | |
028 | 5 | 2 | |a pubmed24n1318.xml |
035 | |a (DE-627)NLM369355474 | ||
035 | |a (NLM)38445712 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bennet, Rutger |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pre-admission virus detection during the COVID-19 pandemic in children with and without symptoms of infection |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 06.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a © 2024 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica. | ||
520 | |a AIM: Pre-admission viral screening is used only in exceptional situations such as pandemics. We therefore evaluated pre-admission screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), respiratory syncytial virus (RSV) and influenza during the COVID-19 pandemic, comparing epidemiology and clinical features of admitted children | ||
520 | |a METHODS: Children were screened at a paediatric emergency department from 1 March 2020 to 30 June 2022 by nasopharyngeal sampling and polymerase chain reaction kit. We retrospectively retrieved positive results from the laboratory and scrutinised charts of admitted children | ||
520 | |a RESULTS: Out of 15 927 screened children, 522, 127 and 572 were positive and admitted with RSV, influenza A or SARS-CoV-2, respectively. Of these, 29 (5.6%), 26 (24.1%) and 245 (44.8%) were incidental findings, lacking symptoms of infection. RSV and influenza A were initially absent but re-emerged in the autumn of 2021. The rate of COVID-19 rose when the Omicron variant emerged in December 2021. The median age of children with RSV was 0.3 years, of those with influenza A 6.7 years and of those with COVID-19 1.6 years. Major complications were rare | ||
520 | |a CONCLUSION: Frequent incidental detections of SARS-CoV-2 likely reflected widespread presence of a mild infection. Clinically, COVID-19 was like other viral respiratory infections in children | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a influenza | |
650 | 4 | |a pre-admission screening | |
650 | 4 | |a respiratory syncytial virus | |
650 | 4 | |a severe acute respiratory syndrome coronavirus 2 | |
700 | 1 | |a Rinder, Malin Ryd |e verfasserin |4 aut | |
700 | 1 | |a George, Eric |e verfasserin |4 aut | |
700 | 1 | |a Hertting, Olof |e verfasserin |4 aut | |
700 | 1 | |a Luthander, Joachim |e verfasserin |4 aut | |
700 | 1 | |a Åkefeldt, Selma Olsson |e verfasserin |4 aut | |
700 | 1 | |a Hammas, Berit |e verfasserin |4 aut | |
700 | 1 | |a Allander, Tobias |e verfasserin |4 aut | |
700 | 1 | |a Eriksson, Margareta |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acta paediatrica (Oslo, Norway : 1992) |d 1994 |g (2024) vom: 06. März |w (DE-627)NLM012619973 |x 1651-2227 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:06 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/apa.17195 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 06 |c 03 |